ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Cycloastragenol reduces inflammation and apoptosis in acute lung injury by inhibiting the NF-κB p65 and Akt pathways.

Huixian Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.